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0022-2836 © 2011 Elsevier Ltd. Open accSmall heat shock proteins form large cytosolic assemblies from an “α-
crystallin domain” (ACD) flanked by sequence extensions. Mutation of a
conserved arginine in the ACD of several human small heat shock protein
family members causes many common inherited diseases of the lens and
neuromuscular system. The mutation R120G in αB-crystallin causes
myopathy, cardiomyopathy and cataract. We have solved the X-ray
structure of the excised ACD dimer of human αB R120G close to
physiological pH and compared it with several recently determined wild-
type vertebrate ACD dimer structures. Wild-type excised ACD dimers have
a deep groove at the interface floored by a flat extended “bottom sheet.”
Solid-state NMR studies of large assemblies of full-length αB-crystallin have
shown that the groove is blocked in the ACD dimer by curvature of the
bottom sheet. The crystal structure of R120G ACD dimer also reveals a
closed groove, but here the bottom sheet is flat. Loss of Arg120 results in
rearrangement of an extensive array of charged interactions across this
interface. His83 and Asp80 on movable arches on either side of the interface
close the groove by forming two new salt bridges. The residues involved in
this extended set of ionic interactions are conserved in Hsp27, Hsp20, αA-
and αB-crystallin sequences. They are not conserved in Hsp22, where
mutation of the equivalent of Arg120 causes neuropathy. We speculate that
the αB R120G mutation disturbs oligomer dynamics, causing the growth of
large soluble oligomers that are toxic to cells by blocking essential processes.© 2011 Elsevier Ltd. Open access under CC BY license.Introduction
All cells can protect themselves from hostile
environmental changes by the stress response
system, which includes increasing the levels of heat
shock proteins (Hsps).1,2 Hsps contribute to
proteostasis3 by binding nonnative proteins, and
they are integrated into cellular networks thatress:
tallin domain; AP,
; sHsp, small heat
e diol; rTEV,
, histidine.
ess under CC BY license.protect the cell from accumulating damaged
proteins.4 Small Hsps (sHsps) form large oligomeric
assemblies with a high capacity for holding onto
nonnative proteins5 that are handed over to the
ATP-driven chaperone machines for refolding.6
sHsps are ubiquitous among the kingdoms of life
and within mammalian genomes occur in large
families with members differentially expressed in
many tissues including muscle, brain and the eye
lens.7–9 Members of the family of 10 human sHsps
(HSPB1–B10) are mainly cytoplasmic.10 αB-Crystallin
(HSPB5), Hsp27 (HSPB1) and Hsp22 (HSPB8)
are cytoprotective, with roles in apoptosis and
autophagy.11,12 A cytoprotective function is a hin-
drance to health when exploited by cancer cells.13
αB-Crystallin behaves as an oncoprotein when
expressed in basal breast cancer14 and blocks
119R120G Mutant of Human αB-Crystallinapoptosis in highly migratory glioma cells,15 making
it a potential drug target.
αB-Crystallin is constitutively and highly expressed
in the eye lens16 and to a lesser extent in skeletal
and heart muscle.7 Cells in these tissues are long-
lived and highly elongated, making them vulner-
able to protein aggregation and deficiencies in
waste-disposal processes.17 Either event will likely
cause upregulation of stress proteins, making
sHsps, in particular, biomarkers of disease in these
tissues.11,18,19 In the brain, αB-crystallin is upregu-
lated in neuron-supporting glial cells during stress,
for example, in astrocytes subject to blockade of
the proteasome.20 In the very early stages of
multiple sclerosis, αB-crystallin is upregulated in
oligodendrocytes that are adjacent to activated
HLA-DR-expressing microglia.21 Severe challenges
to proteostasis can occur on expression of stress
proteins bearing dominant missense mutations as
they signal further stress, leading to more dysfunc-
tional protein. Unsurprisingly, sHsp stress proteins
are associated with swathes of inherited human
diseases, including cataract,22 skeletal myopathies,23
cardiomyopathies24 and neuropathies.25,26
Small Hsp sequences have in common an
“α-crystallin domain” (ACD) of around 90 amino
acids, with most having a short conserved
C-terminal extension bearing an I-X-I motif and a
longer variable N-terminal extension.27 Kingdom-
wide sequence comparisons show subgroups of sHsp
sequences betweenmetazoans and nonmetazoans.28,29
Attention has focussed on an arginine within the
ACD that is conserved across all phyla, as itsmutation
in different sHSP family members causes several
human diseases. Themutation R120G inαB-crystallin
causes desmin-related myopathy.30 The equivalent
arginine mutation (R116C) in αA-crystallin (HSPB4)
causes zonular central nuclear cataracts.31 In Hsp27
and Hsp22, the equivalent substitution (R127W and
K141N/E, respectively) results in neuromuscular
disorders, axonal Charcot–Marie–Tooth disease type
2Fand2L, anddistal hereditarymotorneuropathy.26,32
The sequence conservation of this arginine and the
associated pathogenic mutations in the different
sHsp sequences highlight that it is performing a
general role common to the ACD in many sHsps.
A striking feature of sHsps is their association
into large, soluble, globular assemblies with a
quaternary organisation that allows a variable
number of protomers.5 In vitro, recombinant αB
R120G mutant protein forms soluble oligomers that
are larger and more polydisperse than wild type33
and that are prone to aggregation and precipitation
on handling.34 Although solution polydispersity in
α-crystallins is advantageous for maintaining eye
lens transparency, it is a hindrance for three-
dimensional (3D) atomic characterisation.35 X-ray
crystallography has revealed high-resolution struc-
tures of two well-defined, and hence atypical,assemblies: a 24-mer from an archaeal thermophile36
and a 12-mer from wheat.37 The ACD is an
immunoglobulin-like beta sandwich comprising
strands β2–β9, and the assembly unit is a dimer.
The I-X-I motifs contribute to building dimers into an
assembly by docking into pockets on one side of a
neighbouring ACD beta sandwich. The structural
role of the N-terminal extensions, which emerge
from the other side of the beta sandwich, is less
clearly defined. Single-particle electron microscopy
studies of shell-like 24-mers from archaeal HSP16.5
indicate a buried location,38 whereas in 24-mers from
yeast HSP26, 12 N-terminal domains are buried
inside the assembly and 12 are on the surface.39 Only
6 N-terminal extensions were seen buried within the
double-disc 12-mer in the crystal structure of wheat
HSP16.9,37 where they contributed to holding the
assembly together.
Recent progress in crystallographic structure
determination of vertebrate sHsps has relied on
truncation of the flanking sequence extensions. The
ACD dimers show a mode of dimerisation that is
different from that of nonmetazoans (Fig 1):40–42 the
fewer residues between strands β5 and β7 in
metazoan sequences result in the loss of a distinct
β6 strand, and instead, β7 strand is extended and
referred to as β6+7 strand. This extended strand
interacts about the dimer interface with the equiv-
alent strand in the other chain, whereas in non-
metazoans the β6 strand exchanges between partner
chains at the dimer interface. In effect, an interface
region on one side of the ACD sandwich has
switched from one sheet to the other (Fig. 1).
Sequence differences support these distinct modes
of dimerisation, in particular the presence of a PG
motif in nonmetazoans compared with a KH motif
in metazoans (Table 1). The conserved arginine in
human sHsps is on the β6+7 strand at the dimer
interface, not far from the dyad axis.
The different dimeric arrangements mean that the
ACD side pockets, which are docking stations for I-
X-I C-terminal motifs, are in different relative
orientations in nonmetazoan and metazoan sHsps.
When the I-X-I motif is included in the human αB-
crystallin construct, it binds into ACD pockets,
forming runaway assemblies in the crystal lattice.41
Recent solid-state NMR studies on full-length
human αB-crystallin show the ACD dimer structure
within the context of the assembled oligomer and
also show the binding of the I-X-I motif into ACD
pockets.44 The crystal structure of bovine αA-
crystallin shows that the I-X-I C-terminal motif can
bind in the reverse direction by exploiting its
palindromic sequence.41 In zebrafish αA-crystallin,
the motif can bind into ACD pockets formed from
the same chain.42 These pockets are candidate-
binding sites for nonnative protein substrates.45,46
It has been proposed that a similar motif sequence
in Bag3, a co-chaperone that plays a role in
Fig. 1. The conserved arginine forms an interchain ion pair in the ACD dimers. (a) The mammalian ACD dimer
from human (2WJ7). (b) The plant ACD dimer from wheat, Triticum aestivum (1GME). (c) The bacterial ACD dimer,
from Xanthomonas axonopodis (3GLA). (d) The archaeal dimer, from Methancoccus jannaschii (1SHS). In all structures in
one chain the β7 strand (with the conserved arginine) is coloured brown, the N-terminal β2 strand is green, and the
second molecule in the dimer is yellow. Also, in the β3/4 arch, the ProGly (of nonmetazoans) and LysHis in the
human dimer are shown as sticks. The β-sheet ACD dimer interface that is formed by either the top or bottom β-sheet
is indicated by a blue arrow.
120 R120G Mutant of Human αB-Crystallinmacroautophagy,47 binds into ACD pockets of
Hsp22.12
Although the conserved arginine occurs in two
kinds of structural environment, due to the different
ways in which ACDs dimerise among the king-Table 1. A structural and sequence alignment of the sHsp AC
The β strands for the wild-type αB-crystallin (2WJ7) and wheat HSP1
there is a conserved ProGly (red) in the connection between strands β3
for bulky residues at these positions. In metazoans, this loop is in a diff
the equivalent residues in human αB-crystallin being Lys82His83 (yel
the sequence (green). Also shown is the conserved arginine (cyan) in w
residues that form an interchain ion pair with the conserved argi
phenylalanines that form a hinge-like interaction in metazoans along
align the above sequences and their respective structures (PDB codes 2
not indicated for 2H50 and 2BYU, as they are electron microscopy strdoms of life (Fig. 1), it does form an interchain ion
pair with a topologically equivalent aspartate
(mammals) or glutamate (Table 1) in sHsps of all
other phyla for which high-resolution structural
data are currently available. Within vertebrates,D
6.9 (1GME) are underlined and labeled β2–β9. In nonmetazoans,
and β4 that packs close to the dimer 2-fold axis, leaving little room
erent environment and the ProGly sequence is not conserved, with
low), with a conserved proline now located four residues later in
hich mutations are associated with a number of diseases. Acidic
nine are shown in grey. There are two structurally conserved
the edge of the groove (purple). The T-Coffee server was used to
KLR, 2WJ7, 3L1E, 2WJ5, 1GME, 3GLA, 1SHS).43 The ion pairs are
uctures.
121R120G Mutant of Human αB-Crystallinthere is a source of oligomer heterogeneity that
impacts on the environment of the conserved
arginine and that is the register shift at the dimer
interface. All the structures of the ACDs from
vertebrates solved to date form an antiparallel (AP)
dimer about the β6+7 strand (Fig. 1) that has been
termed the AP interface.41 The register of the
strands can switch, with three different registers
observed (see Supplementary Fig. S1). In both AP2
and AP3 registers, the conserved interchain ion pair
(Arg120–Asp109 in αB) involving the conserved
arginine is maintained.
Here we have solved the X-ray structure of the
ACD dimer of human αB R120G close to physio-
logical pH, as well as higher-resolution αB ACD
wild-type controls. We compared the mutant dimer
structure with several recently determined wild-
type vertebrate ACD dimer crystal structures and
with the solid-state dimer structure resolved in the
context of the full-length sequence in a large
assembly in order to assign the conformational
changes attributable to the R120G mutation.Results
Structure of the mutant αB-crystallin ACD dimer
Two mutations improved the diffraction reso-
lution of crystals of human αB ACD: L137M
substitution and truncation of the β2-strand. The
highest-resolution structure was solved from a β2-
strand truncated construct, αB ACD L137SeM
(residues 71–157). The structure of the human αB
ACD L137SeM (residues 67–157, the same residues
as in 2WJ7) was also solved. The mutation L137M is
located at the surface of a β4/β8 side pocket, and in
human αB ACD L137SeM (residues 67–157) the
crystal packing was different from that of 2WJ7,
even though crystallisation conditions were similar
(Fig. S2). Both the higher-resolution L137SeM αB
ACD structures are very similar to the wild-type αB
ACD (2WJ7), with the RMSD of each construct
(when residues 73–147 are overlaid) equal to 0.68 Å2.
This shows the tolerance for mutation L137M, a
substitution that changes the crystal packing, but not
the core ACD structure. Therefore, the R120G
mutation site was engineered into the longer
L137M construct, but for simplicity, from now on
the R120G/L137M structure will be referred to as
R120G. The RMSD between the high-resolution
71–157 αB ACD (2 Å resolution) and the R120G
ACD (2.5 Å resolution) is equal to 1.589 Å2.
The X-ray structure of the ACD from αB-crystallin
R120G is very similar to that of the wild type, being
composed of strands β2–β9.40,41,44 It is shown
annotated with features common to ACDs in Fig. 2.
There are highly ordered methyl pentane diol (MPD)molecules bound near the β6+7 loops and in the side
pockets, where they mimic the binding of an
isoleucine in the I-X-I C-terminal motif.41
There are now coordinates for several vertebrate
sHsp ACD dimers in the Protein Data Bank
(PDB),40–42,44 which show structural differences.
When two wild-type human αB ACDs (2KLR and
2WJ7) are compared, there are significant differ-
ences between them: these structures were deter-
mined at different pH, with one being an excised
ACD dimer solved by X-ray crystallography and the
other an NMR structure solved in the context of a
large oligomeric assembly. We will now compare all
the vertebrate sHsp structures to help elucidate
those changes caused by the R120G mutation. We
begin by analysing discrete parts of the structure
that show change and then attempt to build a more
complete picture of how the ACD dimer performs
its role.
Variability of the β2 strand
The variable sequence location and conformation
of the β2 strand impacts on the accessibility of the β3
strand. In the R120G and the zebrafish αA (3N3E)
crystal structures, the β2 strand is ordered and
forms a curved β-sheet at a lattice interface, keeping
the adjacent β3 strand covered (Fig. S3). In human
wild-type αB-crystallin ACD (2WJ7), the β2 strand
can be ordered or disordered (Fig. 3a). In the
oligomeric structure of human αB solved by solid-
state NMR (2KLR), β3 strand residues Asp78 and
Val76 are paired with upstream residues Ser59,
Trp60 and Phe61 (termed β2a) from the N-terminal
extension of a separate dimer. The residues equiv-
alent to the β2 strand form a connection between
β2a and β344 (Fig. 3c), referred to as heterogeneity
region 1 (HR1), due to the many structural
conformers that this sequence adopts.44,48
In the rat Hsp20 (HSPB6) structure (2WJ5), the
sequence corresponding to the β2 strand is not
hydrogen bonding with β3, instead it extends across
to a partner domain in the lattice and inserts a
hydrophobic side chain, topologically equivalent to
Met68 in the β2 strand of human αB-crystallin, into
a β4/β8 side pocket. The absence of both β2 strands
from the two top sheets of rat Hsp20 ACD dimer
creates space for the binding of the (C-terminal)
peptide into the shared groove (Fig. 3b).
Taken together, these interchain interactions in the
structures highlight the role in oligomerisation that
the N-terminal and β2 strand sequences might play
and the opportunity for β3 strand to bind variable
partners.
Variability of the bottom β-sheet
The length of the β6+7 strand is determined (in
part) by the number of H-bonds to the β5 strand and
Fig. 2. The structure of the α-crystallin domain of αB-crystallin R120G/L137M. The structure is annotated with the
structural features of ACDs. The β-sheets are labeled and the hairpin loop connecting the β6+7 and β5 strands is
indicated. One of the loops that link the two sheets in each monomer (strand β3 to β4) is shown as the β3/4 arch. The side
pockets at the edges of β4 and β8 are labeled, and the AP dimer interface is labeled. The MPD molecules in the β4/β8
pockets and below the loops are depicted as green sticks.
Fig. 3. Variability and strand swapping at the β3:β2 position. (a) In human αB (2WJ7) the amino acids adjacent to β3
form the β2 strand in one chain of the dimer. (b) In rat Hsp20 (2WJ5) the β2 strand is not part of a β-sheet and (together
with the construct N-terminus) is extended in both chains, allowing a hydrophobic side chain to bind in the β4/β8
pockets of an adjacent dimer. The C-terminal extension of a symmetry-related chain now binds to the β3 strand (shown as
red sticks). (c) In human αB (2KLR) the intrachain β2 strands are not present; however, interactions from upstream N-
terminal residues from another dimer are present. (d) The R120G structure showing intrachain β2 strands for each chain.
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123R120G Mutant of Human αB-Crystallinis correlated with the length of the intervening β6+7
loop. In wild-type αB ACD (2WJ7), at pH 9 the loops
sit up, at almost 90° to the β-sheet (Fig. 4a and b),
whereas in the wild-type αB structure solved by
solid-state NMR (2KLR) and in R120G, the shorter
loops sit below the plane of the β-sheet. The changes
in loop conformation change the surface structure of
the domain around the AP interface.
The αB-crystallin ACD R120G dimer structure is
in the same AP register as the pH 9 wild-type αB-
crystallin ACD (2WJ7) and the pH 7.5 full-length αB-
crystallin solid-state NMR structure (2KLR) and is
close to physiological at pH 7.4. The AP interface is
formed by β-sheet strands β6+7, β5 and β4
extending with the equivalent strands in the other
chain into a larger β-sheet, referred to here as the
bottom sheet. There is considerable flexibility in the
structure of this extended sheet (Fig. 4a). It may beFig. 4. The bottom sheet, strands β6+7, β5 and β4, is varia
type human αB ACD and C-terminal motif, 3L1G (green); w
3L1E (yellow); wild-type zebrafish αAACD and C-terminal m
human αB full-length oligomers, 2KLR (purple); human αB A
wild-type bovine αA ACD and C-terminal motif, 3L1F (brown
structures have varying degrees of curvature. The register is li
the crystal is also noted below the sheet. The loop position is in
strands from the αB structures, looking from the AP dimer inte
β6+7 strands. The loop between the β6+7 sheet and the β5 s
(grey) and pH 4.6 (green). The R120G (red) has longer β-sheets
the wild type. (c) The β6+7 strands from 2WJ7, 2WJ5 and 2KL
strand, whereas the 2WJ7 and 2WJ5 have essentially flat strand
register shift, and not intrinsic curvature of the β-sheet.flat (3L1G, 3L1E and 2WJ7). It may be curved due to
the register of the individual sheets changing, such
as rat Hsp20 (2WJ5), where although the strands
remain fairly flat (Fig. 4c), the two monomers have
moved further away from the midpoint (into
register AP3), creating a concave and convex surface
(Fig 4A). Then, finally, the β-sheets may have an
intrinsic twist, as seen in the solid-state NMR
structure (2KLR) and, to a lesser extent, the two
αA structures (3N3E and 3L1F) (Fig. 4a and c).
It has been suggested that the curvature of the
β-sheet formed by β4, β5 and β6 + 7 is pH
dependent44 based on the difference in curvature
between theNMR structure at pH 7.5 (2KLR) and the
crystal structure at pH 9 (2WJ7). However, the wild-
type αBACD crystal structures (that are now solved)
are both flat at pH 9 and pH 4.6 (3L1G), and the αA
structures at physiological pH are nearly flat (3L1Eble. (a) The wild-type human αB ACD, 2WJ7 (grey); wild-
ild-type bovine αA ACD and C-terminal motif plus zinc,
otif, 3N3E (cyan); the solid-state NMR ACD structure from
CD, R120G (red); wild-type rat Hsp20 ACD, 2WJ5 (blue);
). Note that some structures have a flat sheet, while other
sted below the structures, as AP1, AP2 or AP3. The pH of
dicated with an arrow. (b) An overlay of the β6+7 and β5
rface showing the β6+7 loop position and the length of the
trands sits up at 90° to the sheet in the wild type at pH 9
flanking the loop, and the loop does not sit up like those of
R are overlaid. The 2KLR shows the marked curve in the
s. The curvature observed in rat Hsp20 [in (a)] is due to the
124 R120G Mutant of Human αB-Crystallinand 3L1F), making it unlikely that pH is solely
responsible for the variability seen in the curvature
of the bottom sheet (Fig. 4).
The dynamic AP interface
The AP dimer formed about the β6+7 strands has
been observed in three different registers in the
vertebrate sHsp structures41 (Fig. S1), with the AP1
register having the greatest overlap and AP3 the
least. In addition to the variation in the area of the
AP interface due to the different registers, there is
also the impact of the length of the β6+7 strand
(Fig. 3b). The length of this strand is correlated with
the number of H-bonds across the AP interface and
therefore the dimer interface area. The longer β6+7
strands of the pH 7.5 structure (2KLR) and the
R120G structure form a more extensive interface
than the pH 9 structure (2WJ7). The surface areas of
the various ACD dimer AP interfaces were
analysed by PISA.49 In the wild-type αB-crystallin
(67–157) structure (2WJ7), there are five chains in
the asymmetric unit of the crystal C2 cell, forming
three AP2 interfaces (two noncrystallographic and
one crystallographic) with an average area ofFig. 5. Conservation and variation of charged residues at th
(pH 9). (b) The ACD dimer from full-length wild-type αB-crys
The αB-crystallin ACD R120G structure (pH 7.4). The two ch
forming key interactions at and around the interface are shown
truncated sequence alignment shows that in αA, αB, Hsp27 a
interface are conserved, but vary in Hsp22. Human αB-crystal
those indicated on structures in (a)–(c), and residues that are n
conserved phenylalanine residues (84 and 118) are also shown633 Å2. In the solid-state NMR structure of the
full-length αB-crystallin structure (2KLR), the ACD
dimer interface (also in AP2) has an area of 895 Å2.
With an interface area of 982 Å2, the R120G has a
greater interface than any of the wild-type αB
structures, even when the register and β6+7 sheet
length are considered. This increased surface area
is due to increased intermolecular interactions,
described below. This increase in the dimer inter-
face is also consistent with a tighter dimer interface
for the R120G ACD dimer, shown by gel filtration at
acidic pH.40
The AP dimer interface is likely sensitive to the
environment, especially pH, as it is rich in physio-
logically titratable histidines. All the α-crystallin
dimer structures (αA and αB) solved at physiolog-
ical pH (7–7.5) are in AP2, as well as αB ACD at
pH 9, whereas the more distantly related rat Hsp20
ACD at pH 6.5 (2WJ5) is in register AP3. Lowering
the pH to 4.6 (3L1G), in the case of αB-crystallin,
may cause the register to shift from AP2 to AP1,
which results in disruption of the entire ion pair
network, including the ion pairs between Arg120
and Asp109 (Fig. 5). In 2WJ7 and 2WJ5 these ion
pairs are bidentate, whereas in 2KLR they aree AP interface. (a) The wild-type αB-crystallin ACD (2WJ7)
tallin (2KLR) (pH 7.5), determined by solid-state NMR. (c)
ains are coloured light green and grey, and the residues
as sticks. Interactions are shownwith dashed lines. (d) The
nd Hsp20 the residues involved in the ion pairs at the AP
lin numbering is shown above; residues coloured blue are
ot identical to the αB sequence are coloured red. The two
in purple.
125R120G Mutant of Human αB-Crystallinmonodentate. The presence of bidentate ion pairs
between Arg107 and Asp80 across the AP2 interface
in 2KLR is a major structural difference between the
two wild-type αB structures, the curved 2KLR and
the flat 2WJ7, and may be responsible for the
extensive curvature of the β6+7, β5 and β4 sheet
of 2KLR (Fig. 5).44
While clearly this is a structurally dynamic
interface, the two ion pairs between Arg120 and
Asp109 across the dimer interface are conserved in
the wild-type αB ACD at pH 9 (2WJ7) and the full-
length solid-state NMR αB at pH 7.5 (2KLR) and rat
Hsp20 (2WJ5) (Fig 1 and Table 1). This interaction is
even maintained when there is a register shift, from
AP2 to AP3 (rat Hsp20) and when there is an
increase in pH. It is this pair of salt bridges that is
disrupted in the pathogenic mutation R120G (Fig. 5).
Arg120 is part of an extensive ionic interaction
network that crosses the dimer interface (Fig 5).
Sequence alignments show a set of residues (Asp 80,
His83, Arg107, Asp109, His111, Arg116, Arg120)
that is conserved in αB, αA, Hsp27 and Hsp20, yet
they are all different in Hsp22 (inset in Fig 5). This
strengthens the case that these charged side chains
are functionally connected and that Hsp22 has
diverged. In muscle αB, Hsp27 and Hsp20 can
form co-oligomers,50 and αA, αB and Hsp27 have
been shown to co-oligomerise and exchange sub-
units in vitro in a temperature-dependent manner51
as have Hsp27 and Hsp20.52 Although co-assembly
of Hsp22 with Hsp27 is less clear, there is cell
biological evidence that mutant Hsp22 interacts
more avidly with Hsp27 than wild-type Hsp22.32 If
sHsps use this interface to bind unrelated protein
partners (for insertion into networks) or nonnative
protein substrates (as a chaperone), then the
distinctive Hsp22 AP interface may facilitate bind-
ing of different partners and substrates from the
other sHsps.
Changes to the charged groove at the mutant
AP interface
The sHsp wild-type ACD X-ray structures all have
a deep groove that runs down the AP dimer
interface. The groove is maintained through se-
quence changes, register shifts and across a wide pH
range (Fig. 6). The base of the groove is lined with
four arginines, Arg120 and Arg116 on each of the β6
+7 strands. The change in Arg120 to Gly120 results
in the loss of two positive charges along the
interface. This in turn results in loss of two interface
ion pairs between Arg120 and Asp109 and gain of
two new interface ion pairs between His83 and
Asp80 (Figs. 5 and 6). These ion pairs between
Asp80 and His83 are not observed in any of the
currently available wild-type αB ACD structures.
Both residues are on an arch between strands β3 and
β4 that links the top sheet to the bottom sheet in theACD on each side of the groove (Fig. 2). Movement
of these arches toward each other to form two pairs
of interchain salt bridges blocks the groove (Fig. 5).
In the wild-type αB 2KLR structure the cleft is also
absent, but in this case the bottom sheet curves up
into the area between the top sheets (β3, β9 and β8)
(Fig. 7).
The ability to open and close the groove may be
facilitated by two phenylalanines that are conserved
in all metazoan ACDs (purple in the alignment in
Table 1 and the inset in Fig. 5). In the 3D structures,
they are on the edge of the shared groove (αB
residues 84 and 118) and interact by edge-to-face
stacking of the side chains (Fig. S4). In the NMR
structure of αB (2KLR), Phe118 also interacts with
Arg116 across the AP interface via a pi–cation
interaction.44 Arg116 makes an intrachain cation–
aromatic interaction with His83 in αB (2WJ7) at
pH 9, αA (3L1E) at pH 7 and αA (3L1F) at pH 7.5
(yellow in Table 1). This set of amino–aromatic
interactions is embedded under the network of ionic
interactions. As His83 is in a central position, it may
respond to pH changes. In 2KLR, the interaction
between His83 and Arg116 is broken, as it is in the
crystal structures of rat Hsp20 (2WJ5) at pH 6.5, αB
(3L1G) at pH 4.6 and αA (3N3E) at pH 6. In 2KLR,
the altered position of Phe118 correlates with the
bottom sheet being twisted (Fig. 7).
It is possible that the ACD dimer is able to
fluctuate between open- and closed-groove confor-
mations, with a closed state being favoured in the
oligomer and the open state in the dissociated
dimer. The structure of the R120G indicates that in
the mutant this dynamism would be dampened.Discussion
Biophysical methods indicate that in solution
αB-crystallin is polydisperse in size and in rapid
dynamic equilibriumwith subassembly species.5,16,35
We now propose, from analysing the 3D structures
of ACD dimers currently available in the PDB, that
the dimer itself exhibits conformational flexibility.
Using N-terminally truncated sHsp sequences, crys-
tallography has captured snapshots of dimers
bearing a deep, shared groove at the dimer interface
that is conserved in the structures of vertebrate ACDs
of αB, αA and Hsp20.40–42 In the solid-state NMR
structure, the αB ACD dimer has conformational
differences from those solved by crystallography.44
The extended β-sheet, formed by strands β4, β5 and
β6+7, is essentially flat in the crystal structures;
however, in the NMR structure it is twisted, more
like the shape of a hyperbolic paraboloid. The
twisted bottom β-sheet curves up and fills the
groove space. This form of αB-crystallin ACD dimer
with the groove in a closed state either does not
crystallise or exists only in the full-length highly
Fig. 6. The conserved positively charged groove along the AP interface is lost in R120G. This groove is conserved in
wild-type ACD structures of human αB [2WJ7 (a) and 3L1G (b)], bovine αA (3L1F) (c) and rat Hsp20 (2WJ5) (d). In the
R120G, the groove is absent, due to ion pairs between Asp80 and His83, on the arches connecting top (β3, β9 and β8) and
bottom sheets, β-sheets having moved closer to the centre in R120G. (e) The groove is closed in the ACD dimer from full-
length wild-type αB-crystallin (2KLR).
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ACD dimer also reveals a closed groove, but in the
mutant closure is caused by a pair of salt bridges
between His83 and Asp80 close to the dimer 2-fold
axis. The His83–Asp80 ion pair is not observed in
any of the wild-type ACD dimer structures currently
available. The two structures with closed grooves
were solved at pH 7.4/5.
In the structures of Hsp20, αA and αB, there are
molecules (peptide, MPD and sulfate) that have co-
crystallised in the AP groove (Fig. 8). This highlightsthe groove as a potential binding site for polypeptides
and small molecules. The function of this dynamic
groove down the AP interface may be to bind a
phosphate-containing small molecule, which could
allow regulation of these sHsps. In the wild-type αB
structure (3L1G), a sulfate is bound at the 2-fold
interface in the dimer (Fig. 8). Early experiments
showed that ATP modulated the limited digestion of
αB-crystallin with trypsin or chymotrypsin, which
indicated that it could exert a conformational change
of the ACD.53 When the residues with a nucleotide-
Fig. 7. Closing the groove in two different ways. (a) The wild-type αB-crystallin ACD (grey) showing the deep groove.
(b) In the full-length wild-type αB-crystallin (blue) the lower β-sheet has moved up into the space where the groove was in
structure (a). (c) In the R120G αB-crystallin ACD (red) the β3–β4 arches have moved into the groove. In (b) and (c) the
2WJ7 structure is shown in grey, overlaid with the second structure shown in either blue (2KLR) or red (R120G).
127R120G Mutant of Human αB-Crystallindependent protease susceptibility are mapped onto
the crystallin domain, they are located around the site
of the sulfate molecule, lining the groove at the AP
interface (Supplementary Fig. S5). It is possible thatthe sulfate in 3L1G may be bound in an ATP (or
similar compound) binding site.
Recombinant full-length αB R120G mutant pro-
tein forms a soluble oligomer that is both larger and
Fig. 8. Groove as a binding site for other molecules. (a) The rat Hsp20 ACD has the C-terminal of a chain from an
adjacent dimer bound in the groove. (b) The human wild-type αB ACD (3L1G) has a sulfate bound at the crystallographic
2-fold interface between the molecules. (c) The bovine wild-type αA has two MPD molecules bound in the groove.
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129R120G Mutant of Human αB-Crystallinmore polydisperse than wild type33 and is prone to
aggregation and precipitation on handling.34 The
mutation thus disturbs higher assembly of the
oligomer, and the crystal structure of R120G
ACD shows a dimer with a blocked groove. The
N-terminal extension of αA has been shown to be
necessary for its higher assembly.51 The solid-state
NMR study provides evidence for the N-terminal
extension playing a role in the oligomerisation of
αB-crystallin by showing that the region around
Trp60 (in what is termed the β2a strand) interacts
with the β3 strand from a different dimer.44 It is
possible that the N-terminal extension is involved in
regulation of assembly. We speculate that these
extensions may bind in the open groove in the
full-length subassembly state, as the rat Hsp20
C-terminus binds in the Hsp20 groove in the crystal
structure (in 2WJ5). In this scenario, the burial of the
largely hydrophobic N-terminal extension may
drive the dissociation of the dimer out of the higher
oligomer.
How might these structural observations contrib-
ute to understanding how mammalian sHsps
function? αB-Crystallin, in common with other
more regular nonmetazoan sHsp assemblies, is in
dynamic equilibrium in solution with subassembly
species.51,54,55 The R120G with its new set of ion
pairs would favour the ACD dimer in the closed
form and disturb the subunit-exchange-driven
assembly dynamics. Recently, an investigation of
the quaternary dynamics of pea HSP18.1 has shown
how heat can cause the regular assembly to increase
in size and polydispersity, along with increased
dissociation into subassembly species, in a reversible
manner.56 These authors show evidence that this
thermal plasticity correlates with chaperone activity.
Stress in mammalian systems can be relayed by
kinases, with serines in human sHsps often being
phosphorylated. In Hsp27, there is clear evidence for
their phosphorylation causing dissociation into
smaller oligomers.57,58 In keeping with our specula-
tive model of the released N-terminal extension
binding the open groove of a dimer, the four
arginines in the groove may bind with higher
affinity to the phosphorylated N-terminus, favour-
ing the dissociated state. The groove may also be a
site of regulation, as reflected by a number of small
molecules that have co-crystallised in it and from the
evidence that ATP might bind here accompanied by
a structural rearrangement.53 The depth of the
cleft and its possible role in the function of wild-type
αB-crystallin make this region a possible candidate
site for drug design.
The R120G mutant is a defective chaperone and
coaggregates with other destabilised proteins in
chaperone assays.33 This may be due to the
mutation disturbing the subunit exchange dynam-
ics, although for αB-crystallin, there is evidence that
the efficiency of exchange is only slightly decreasedby the R120G mutation59 or is increased.34 The
groove may also be a client substrate-binding site
(chemical probes also label β3 strand sequence45)
whose access is regulated through the dynamics of
the assembly in ways that involve the dynamics of
the N-terminal extension. In a well-characterised
nonmetazoan sHsp system for detecting substrate-
binding sites, both the N-terminal extension and β7
strand bound substrates.60 However, the solution
state of the dissociated full-length αB-crystallin
dimer is not yet accessible to standard structural
methods, and the geometric locations of the groove
and ACD pockets are not defined in the ambient or
in the activated forms of αB-crystallin. Our provi-
sional model for how sHsps might bind substrates
involves unfolded polypeptide chains wrapping
around ACD domains by docking into substrate-
binding regions formed by the shared groove and
β4/β8 pockets. Support for this model comes from
the X-ray structure of an sHsp from a parasitic
worm, where completely resolved N-terminal exten-
sions wrap around a set of four ACDs.61
Forced expression of αB R120G is highly toxic to
cells.62 It causes activation of the aggresome
pathway,63 with formation of massively aggregated
bodies in the cell, similar to the effects caused by
blockage of the proteasome.20 Animal models that
overexpress αB R120G in heart muscle cells have
increased levels of amyloid and develop
cardiomyopathy.64 The ability of R120G to form
oligomers larger than wild type yet with some
solubility may be the basis of its toxicity causing it to
aggregate over time with crucial cellular compo-
nents, possibly blocking or overwhelming the
waste-disposal systems in muscle cells. Similar
damage has been suggested to cause motor-
neuron-specificneuritedegenerationwhen thesequence
equivalent mutation, Hsp22 K141N/E, is expressed
in elongated cultured primary neuronal and glial
cells.65 In the eye lens, wheremost cellular organelles
have faded away, R120G likely causes cataract by
binding to other crystallins, causing aggregation that
then scatters visible light.Methods
Protein expression and purification
Three protein constructs of human αB-crystallin that
encoded the residues of the ACD were used: αB L137M
(residues 71–157), L137M (residues 67–157) and R120G/
L137M (residues 67–157). Themutations R120G and L137M
were generated by QuikChange® PCR mutagenesis, both
in the longer construct (residues 67–157). After purification
and recombinant tobacco etch virus (rTEV) cleavage of the
histidine (His) tag from this construct, all the recombinant
proteins contained three extra residues at the N-terminus,
GAM.
130 R120G Mutant of Human αB-CrystallinThe L137SeM (71–157) and L137SeM (67–157) constructs
in the pProEx™ Ht(b) vector were expressed in Escherichia
coli grown in SelenoMet™ medium base (Athena Enzyme
Systems) with a hexahistidine affinity tag and purified by
Ni chromatography, rTEV cleavage, and then gel filtration,
as previously described for the wild-type αB-crystallin
domain.40
To purify the R120G/L137M protein, a slightly different
purification was used. Cells from a 6-L culture were lysed
in buffer A (0.5 M NaCl, 50 mM potassium phosphate,
pH 8) containing 20 mM imidazole and an EDTA
(ethylenediaminetetraacetic acid)-free protease inhibitor
cocktail tablet (Roche) by a cell disruptor (EmulsiFlex-C5,
AVESTIN), and then briefly sonicated to shear the DNA.
The cellular debris and any remaining whole cells were
removed by centrifugation (20,000g for 30 min) and
filtered through a 0.45 -μm filter. The protein solution
was then loaded onto a preequilibrated 5 -mL HisTrap™
HP column (GE Healthcare). The unbound proteins were
removed with 10 column volumes of buffer A containing
20 mM imidazole. The proteins were then eluted in a
stepwise imidazole gradient of buffer A containing 100,
150 and 250 mM imidazole, with the recombinant protein
eluting in the 250 mM fractions. These fractions were
pooled and dialysed into buffer [25 mM Tris–HCl (pH 8),
100 mM NaCl, 1 mM DTT] at 4 °C. Then rTEV protease
was added (100:1 ratio of substrate/protease) and
incubated at 4 °C for 2 days to cleave the His tag. The
protein was then dialysed into buffer A (also containing
20 mM imidazole) and the flow-through from a second
preequilibrated 5 -mL HisTrap™ HP column was
collected. This step removes the His tag, rTEV and any
uncleaved recombinant protein that binds to the Ni
column. The eluant was then further purified by gel
filtration on a Superose75 HR10/60 column, in buffer
(25 mM NaCl, 25 mM Tris–HCl, pH 8). Fractions
containing the recombinant protein were pooled, concen-
trated to 16.5 mg/mL (as determined by A280 using an
extinction coefficient of 1446 M−1 cm−1) and stored at
−80 °C.
Crystallisation
Crystals were all produced using the vapour-diffusion
technique; the conditions used for each construct are
provided below. Following crystallisation, crystals
were mounted in a loop in the drop solution (all
conditions contained MPD concentrations sufficient for
cryoprotection) and flash-frozen by immersion in liquidN2.
L137SeM αB (71–157) pH 9
One microlitre of protein at 20 mg/mL in buffer [25 mM
Tris–HCl (pH 8.5), 200 mM NaCl] was mixed with 1 μL of
mother liquor [40 mM bicine (pH 9.0), 40% MPD] and
equilibrated against wells containing 50 μL of mother
liquor and incubated at 4 °C.
L137SeM αB (67–157) pH 9
One microlitre of protein at 20 mg/mL in buffer [25 mM
Tris–HCl (pH 8.5), 200 mM NaCl] was mixed with
110 mM bicine (pH 9.0) and 55% MPD and equilibrated
against wells containing 50 μL of mother liquor at 16 °C.R120G/L137M αB (67–157) pH 7.4
One microlitre of protein at 16.5 mg/mL in buffer
[25 mM Tris–HCl (pH 7.5), 25 mM NaCl] was mixed with
1 μL of mother liquor (36% MPD, 0.18 M potassium
chloride), giving a final pH of 7.4 in the drop solution.
Sitting drops were then equilibrated against wells contain-
ing 50 μL of mother liquor at 16 °C.
Structure determination
L137SeM αB (71–157)
Data were collected at the Diamond Light Source,
beamline I02, on an ADSC CCD detector. Eight hundred
images with an oscillation angle of 0.45° were collected at
a wavelength of 0.9794 Å. Initial indexing indicated point
group 422. Following integration with Mosflm66 and
scaling with Scala,67 systematic absences showed the
space group to be P41/322 with one molecule in the
asymmetric unit (giving a Matthews coefficient of 2.0 and
a solvent content of 38%). Data processing statistics are
shown in Table 2.
The structure was solved by molecular replacement
using Phaser68 and the wild-type αB-crystallin (PDB code
2WJ7) lacking the β2-strand as a model. The solution was
in space group P4322 and had a Z score of 19.6 and an
initial R-factor of 45.6%. Rounds of refinement with
Phenix,69 alternating with manual rebuilding with Coot,70
resulted in a final R and Rfree of 20.4% and 22.1%,
respectively. Refinement utilised automatic water picking,
TLS refinement (with two domains corresponding to
residues 10–58 and 59–87, or each of the two β-sheets)
and refinement of the anomalous signal from the single
ordered selenomethionine residue. An ordered MPD
molecule was observed in the density proximal to Ser135
in the β4/β8 ACD binding pocket.
L137SeM αB (67–157)
Data were collected at the European Synchrotron
Radiation Facility (ESRF), beamline 14-1, where diffrac-
tion for this crystal extended to 3.7 Å. Three hundred and
sixty images with an oscillation angle of 1° were collected
for each of three wavelengths (peak at 0.978 Å). Initial
indexing showed the data to be in point group 222.
Following integration withMosflm and scaling with Scala,
systematic absences indicated the most likely space
groups to be P2122 or P21212. Six α-crystallin domains in
the asymmetric unit of this cell result in a Matthew's
coefficient of 2.59 and an estimated solvent content of 52%.
Data collection statistics are provided in Table 2.
The structure was solved by molecular replacement
using Phaser and the higher-resolution L137SeM (71–157)
coordinates as a model. Initially, four chains could be
placed with good density, with a Z score of 25.7 and an
initial R-factor of 48.5% in space group P21212. However,
these four chains did not form a lattice, and inspection of
the initial maps revealed areas of positive density between
the layers of molecules placed by Phaser. An additional αB
ACD dimer was placed in this density by inspection, thus
completing the lattice. The L137SeM low-resolution data
set, originally collected as part of a multiwavelength
anomalous dispersion experiment, was intended for use
in structure solution. A significant anomalous signal is
Table 2. X-ray data collection and refinement statistics
L137M residues 71–157 L137M residues 67–157 R120G/L137M residues 67–157
Crystal parameters
Space group P4322 P21212 P3221
Cell dimensions (Å) a=36.03, b=36.03, c=148.32 a=67.12, b=78.42, c=130.67 a=60.73, b=60.73, c=100.15
Angles (°) α=β=γ=90 α=β=γ=90 α=β=90°, γ=120°
Data collection
Wavelength (Å) 0.9794 0.978 0.8726
Resolution limit (Å) 2.0–35.01 (2.11–2.0) 3.7–67.24 (3.90–3.70) 2.50–46.56 (2.64–2.50)
Mosaicity 0.4 0.6 1.3
Rmerge 0.097 (0.322) 0.236 (0.66) 0.099 (0.536)
Ranom 0.039 (0.066) 0.058 (0.169)
Total no. of observations 184850 (27285) 100933 (14795) 69470 (9859)
Total no. unique 7272 (1018) 7861 (1109) 7582 (1087)
Mean I/σI 25.6 (11.6) 8.7 (4.0) 19.4 (4.3)
Completeness 100.0 (100.0) 100.0 (100.0) 98.0 (97.8)
Anomalous completeness 100.0 (100.0) 100.0 (100.0)
Multiplicity 25.4 (26.8) 12.8 (13.3) 9.2 (9.1)
Anomalous multiplicity 14.6 (14.7) 7.0 (7.1)
Refinement
Reflections 12582 7846 6777
Protein atoms in model 624 3342 1405
Solvent atoms in model 58 0 14
Rworking 0.204 0.213 0.173
Rfree 0.221
a 0.277b 0.241c
RMSD from ideal geometryd
Bond lengths (Å) 0.003 0.012 0.006
Bond angles (°) 0.67 0.28 0.98
Wilson B-factor (Å2) 21.4 56.1 43.7
B-factor of protein atoms (Å2) 33.6 88.8 31.2
B-factor of solvent atoms (Å2) 44.2 17.2
Ramachandran plotd
Most favoured (%) 97.4 95.8 97.0
Outlier (%) 0.0 0.44e 0.6f
PDB code 2Y1Y 2Y22 2Y1Z
Overall values are listed, with the outer-shell values in parentheses.
Rmerge=∑|Ii−bIiN|/∑Ii.
Rworking=∑|Fo−Fc|/∑Fo.
Rfree is the R-factor calculated for the cross-validated test set of reflections.
a Rfree is 4.67% of reflections.
b Rfree is 4.78% of reflections.
c Rfree is 10.4% of reflections.
d As defined by MolProbity.
e Outliers are Glu67 in chain A and Glu106 in chain C, in poor density.
f Outlier is Asp109 in chain A, in poor density.
131R120G Mutant of Human αB-Crystallinpresent in these data that has been used as an independent
source of experimental phases to confirm the location of
the poorly ordered chains. There are small but significant
(3.5σ) electron density peaks corresponding to SeMet 137
for both poorly ordered chains and also for SeMet 68 from
molecule E in anomalous difference maps calculated
using peak wavelength data and phases from the final
refined model with the two weak chains omitted. In
addition, there is weak but significant density to support
the location of the poorly ordered chains in maps
calculated using phases optimised with Phaser from
data collected at the peak wavelength and the partial
molecular replacement solution consisting of the four
well-ordered chains. This density is strongest where the
two additional chains make crystal contacts with the rest
of the structure, as might be expected.
Refinement was carried out with Refmac 5.671 utilising
local NCS restraints and the new Jelly Body refinementprotocol and was alternated with manual building using
Coot. The final R and Rfree were 21.3% and 27.7%,
respectively. Density for possible MPD molecules was
seen in the same location as for the high-resolution
structure, close to Ser135 for the four ordered chains
initially placed by Phaser. Additional density that could
correspond to MPD molecules was seen on the other side
of this serine for three of these molecules.
R120G/L137M (67–157)
Data were collected at ESRF, beamline 14.4, as 77
images, each with a 2° oscillation angle, at a wavelength of
0.87 Å. Data from 2.5 to 46.3 Å were integrated and
indexed by Mosflm and then scaled with Scala (Table 2).
The space group and point group were uncertain due to a
combination of probable twinning and missing axial
reflections. The apparent point group was P6, and the
132 R120G Mutant of Human αB-Crystallinlikely space groups were P3n or P3n21, where the nature of
the screw axis was not known. Solutions were determined
by molecular replacement using the L137SeM structure
(residues 71–157) in Phaser in a number of space groups.
The solution in P3221 refined to sensible R-factors.
Building by hand in Coot and intensity-based twinning
refinement in Refmac (final twin fraction of 47%) resulted
in final R and Rfree of 17.3% and 24.0%, respectively, with
good geometry as determined my MolProbity.72 All
structures were processed with the CCP4 program
suite,73 and images were generated with PyMOL.
PDB accession numbers
Coordinates and structure factors have been deposited
in the PDB. For human αB R120G/L137M (67–157), the
PDB code is 2Y1Z for the coordinate entry, and the code is
R2Y1ZSF for the structure factors. For human αB L137SeM
(67–157), the PDB code is 2Y22 for the coordinate entry,
and the code is R2Y22SF for the structure factors. For
human αB L137SeM (71–157), the PDB code is 2Y1Y for
the coordinate entry, and the code is R2Y1YSF for the
structure factors.
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